UK GPs Spend 39% Of Their Time On Minor Ailments

24 March 1997

UK general practitioners estimate that 39% of their time with patientsis taken up dealing with minor ailments which do not require the attention of a doctor, according to a new survey, commissioned by the Proprietary Association of Great Britain, from PMSI. A national representative sample of 200 GPs was interviewed face-to-face last October.

Family doctors believe that an over-the-counter medicine recommendation is an integral part of GPs' treatment approach for minor ailments (32% strongly agree and 28% disagree). This may be why GPs are asking patients with minor ailments whether they have tried an OTC medicine. In this survey, 38% said they always asked their patients about OTC use and 45% said they frequently asked.

The study also revealed that a high proportion of GPs are making records on patients' notes when recommending OTCs, with 39% always doing so and 32% frequently recording.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight